Search Results 71-80 of 22860 for Lateral
Clinical Trials · A Study to Explore the Safety and Tolerability of Acthar in Patients With Amyotrophic Lateral Sclerosis · More about research at Mayo Clinic.
... lateral sclerosis (ALS), peripheral neuropathy, muscular dystrophy and myasthenia gravis. ... Researchers in the Department of Neurology's Amyotrophic Lateral ...
The purpose of this study is to evaluate the effect of retigabine dosages on motor neuron activity in people with Amyotrophic Lateral Sclerosis (ALS).
Learn about this condition that causes pain and swelling in muscles of the legs or arms during exercise.
The purpose of this study is to assess the effect of Reldesemtiv versus placebo on functional outcomes in Amyotrophic Lateral Sclerosis (ALS). Participation ...
A Dose-escalation Safety Trial for Intrathecal Autologous Mesenchymal Stem Cell Therapy in Amyotrophic Lateral Sclerosis · Overview · Participation eligibility.
This first-in-human, double-blind, placebo-controlled Phase I study will be conducted in participants with amyotrophic lateral sclerosis (ALS) to explore safety ...
The purpose of this study is to determine the overall accuracy of a cerebro-spinal fluid (CSF) based test for the diagnosis of amyotrophic lateral sclerosis ...
Myocardial ischemia reduces blood flow to the heart and may cause chest pain – but not always. Learn all the signs and symptoms and how to treat it.
The purpose of this study is to assess the safety and effectiveness of NP001 for the treatment of patients who have amyotrophic lateral sclerosis (ALS) and ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.